Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Oxandrolone
Drug ID BADD_D01634
Description A synthetic hormone with anabolic and androgenic properties.
Indications and Usage Use to promote weight gain after weight loss following extensive surgery.
Marketing Status Prescription; Discontinued
ATC Code A14AA08
DrugBank ID DB00621
KEGG ID D00462
MeSH ID D010074
PubChem ID 5878
TTD Drug ID D0U3GL
NDC Product Code 62991-2699; 51552-1579; 0245-0271; 58159-046; 55486-1570; 64181-0003; 65129-1066; 63275-9962; 63629-7603; 0245-0272; 49884-302; 49884-301
Synonyms Oxandrolone | Oxandrin | SC-11585 | SC 11585 | SC11585 | Anavar
Chemical Information
Molecular Formula C19H30O3
CAS Registry Number 53-39-4
SMILES CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acne23.02.01.001--Not Available
Agitation17.02.05.012; 19.06.02.001--
Alanine aminotransferase13.03.01.031--Not Available
Aspartate aminotransferase13.03.01.032--Not Available
Azoospermia21.03.03.001--
Bladder irritation20.02.02.020--Not Available
Blood bilirubin increased13.03.01.008--
Blood calcium increased13.11.01.003--Not Available
Blood chloride increased13.11.01.005--Not Available
Blood creatine phosphokinase increased13.04.01.001--
Blood creatinine increased13.13.01.004--
Blood gonadotrophin decreased13.10.03.001--Not Available
Blood potassium increased13.11.01.011--Not Available
Bromosulphthalein test abnormal13.03.01.022--Not Available
Chronic obstructive pulmonary disease22.03.01.007--Not Available
Clitoral engorgement21.08.02.006--Not Available
Death08.04.01.001--
Depression19.15.01.001--
Dysphonia17.02.08.004; 19.19.03.002; 22.02.05.005--
Electrolyte imbalance14.05.01.002--Not Available
Enlarged clitoris05.05.01.004; 21.08.02.001--Not Available
Epididymitis11.01.19.005; 21.09.02.001--Not Available
Epiphyses premature fusion05.05.03.002; 15.02.02.001--Not Available
Erection increased19.08.04.002; 21.03.01.004--Not Available
Fluid retention14.05.06.002; 20.01.02.003--Not Available
Glucose tolerance decreased13.02.02.004--Not Available
Gynaecomastia05.05.02.003; 21.05.04.003--
Haemoglobin13.01.05.018--Not Available
Hepatic necrosis09.01.07.002--
Hepatic neoplasm09.04.03.001; 16.07.03.001--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages